Simplex Trading
CARM

Simplex Trading’s Carisma Therapeutics CARM Stock Holding History

Simplex Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,235
Closed -$271K – 9084
2022
Q4 		$271K Buy
22,235
+10
+0% +$105 ﹤0.01% 3862
2022
Q3 		$188K Buy
22,225
+7,350
+49% +$100K ﹤0.01% 4695
2022
Q2 		$241K Sell
14,875
-265
-2% -$3.03K ﹤0.01% 4384
2022
Q1 		$182K Sell
15,140
-4,945
-25% -$69.1K ﹤0.01% 5293
2021
Q4 		$327K Buy
20,085
+17,900
+819% +$360K ﹤0.01% 4421
2021
Q3 		$197K Buy
2,185
+10
+0.5% +$480 ﹤0.01% 5603
2021
Q2 		$200K Buy
2,175
+2,115
+3,525% +$135K ﹤0.01% 5680
2021
Q1 		$313K Buy
60
+58
+2,900% +$2.74K ﹤0.01% 4093
2020
Q4 		$4K Sell
2
-1
-33% -$25 ﹤0.01% 7773
2020
Q3 		$7K Buy
+3
New +$60 ﹤0.01% 6942
2020
Q2 		– Sell
-58
Closed -$65K – 7649
2020
Q1 		$65K Buy
58
+46
+383% +$754 ﹤0.01% 4851
2019
Q4 		$25K Buy
12
+11
+1,100% +$253 ﹤0.01% 5783
2019
Q3 		$1K Buy
+1
New +$23 ﹤0.01% 7019
2018
Q2 		– Sell
-19
Closed -$63K – 7379
2018
Q1 		$63K Buy
+19
New +$365 ﹤0.01% 2196

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Simplex Trading's CARM Position: Q1 2022 in Review

Simplex Trading sold out of Carisma Therapeutics (CARM) in Q1 2022, closing a stake of 2,037 shares — an estimated $28.5K sold.

Simplex Trading first reported a position in CARM in Q1 2018 and held it in 10 quarters. The position peaked at $616K in Q2 2021. 84 funds tracked by Wall St. Rank hold CARM as of Q1 2022.

  • Simplex Trading reported no remaining Carisma Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 2,037 Carisma Therapeutics shares in Q1 2022, an estimated $28.5K.
  • Simplex Trading first reported a position in Carisma Therapeutics in Q1 2018 and held it in 10 quarters.
  • Simplex Trading's Carisma Therapeutics position peaked at $616K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.